At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 42 enrolled
Drug / intervention
S(+)-Ketaminedrug
Likely dose
S(+)-Ketamine 0,3mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of S(+)-Ketamine Administered as a Continuous Infusion for the Control of Postoperative Pain: a Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating S(+)-Ketamine for Postoperative Pain. Completed, enrolled 42 participants across 1 site.
Detailed Summary
Background: The use of low-dose continuous infusion of S(+)-ketamine combined with target-controlled intravenous anesthesia with remifentanil and propofol may be related to the control of postoperative pain and of opioid-induced hyperalgesia. The present study aimed to evaluate the efficacy of continuous infusion of S(+)-ketamine given intraoperatively in the control of postoperative pain compared to placebo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesBrazil
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2012
Primary CompletionFeb 2014
Study CompletionFeb 2015
First PostedApr 2015
TodayJul 2026
First PostedApr 21, 2015
Enrollment StartJun 1, 2012
Primary CompletionFeb 1, 2014
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.2 years ago
Interventions
S(+)-Ketaminedrug
S(+)-Ketamine 0,3mg/kg/hr intraoperative